Navigation Links
Users of Gene-Eden, a Natural Antiviral, Report less Sleeping Problems in a Recent Study
Date:10/14/2009

In a recent study, people who suffer from sleeping problems report better sleep with Gene-Eden, a natural supplement that targets many common chronic viruses.

Rochester, NY (PRWEB) October 14, 2009 -- Recently, polyDNA conducted a series of interviews with users of the natural antiviral Gene-Eden. Analysis of the interviews revealed that the users of the supplement experience less sleeping problems, that is, better sleep relative to the time before taking the supplement.

Trouble sleeping? Recent scientific studies show that the cause of many sleeping problems might be an infection with a chronic virus. As Professor Mark Opp, from the Medical School at the University of Michigan, said: "Data reviewed demonstrate the extent to which sleep is altered during the course of (an) infection."

One of the studies, which showed the relationship between chronic viruses and sleeping problems, was conducted by a team of scientists headed by Professor Jose G. Montoya from the School of Medicine at Stanford University. The study showed that treatment with the antiviral drug valganciclovir benefited many people who suffered from a sleep disorder. In the study, the scientists gave the drug to a group of patients who were suffering from sleep disturbances, and who had a high concentration of chronic viruses in their body. The drug worked. It resolved the sleeping problems in 75% of these patients!

Gene-Eden: antiviral dietary supplement for better sleep

Gene-Eden is an all natural, broad range, antiviral dietary supplement that targets many common viruses during their latent or chronic infection phase. These viruses include the Epstein-Barr virus (EBV), Herpes Simplex virus (HSV), Cytomegalovirus (CMV), Varicella Zoster virus (VZV), Human Papillomavirus (HPV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and other less known viruses.

The Gene-Eden formulation is based on five natural ingredients. To identify these ingredients, the scientists at polyDNA used a unique process. First, they collected thousands of scientific papers. Then, they analyzed the content of these papers with their in-house, proprietary bio-informatics computer program. Finally, they used the results of the computer analysis to select the five most powerful and safe antiviral ingredients.

Some of the papers identified by the computer analysis that show the powerful antiviral effect of the five ingredients are available on the Gene-Eden website.

Recently, polyDNA conducted a series of interviews with users of the antiviral Gene-Eden. In these interviews the polyDNA representatives asked the participants about their sleeping experiences before and after using the supplement. For instance, the representatives asked how many times a night the participant wakes up on average, or how long does it take to fall back asleep. The analysis of the answers to these questions revealed that the users of Gene-Eden experience less sleeping problems, that is, better sleep relative to the time before taking the supplement.

What is the difference between Gene-Eden and sleeping pills like Ambien or supplements like melatonin?

According to the Consumer Reports website, "Most sleep drugs are supposed to be taken for no longer than two weeks or so, and continued use could lead to serious side effects or dependency; "rebound" insomnia, in which sleeplessness returns and might actually worsen; memory lapses; and hallucinations."

Why do people experience these side effects? Because sleeping pills like Ambien and supplements like melatonin change the chemistry in the brain. These sleeping pills induce sleep by creating an artificial chemistry in the user's brain. However, this artificial chemistry is … artificial, and as such, is responsible for the serious side effects.

Moreover, since the brain is adoptive, overtime the users of these pills can no longer fall asleep without inducing the artificial chemistry, that is, without taking the sleeping pills.

In contrast to these artificial sleeping aids, Gene-Eden targets the chronic viruses in the body, a common cause of sleeping problems. Gene-Eden does not induce an artificial chemistry. It rather recreates the more natural, healthy state, typical of a person with little or no chronic viruses, a person that experiences uninterrupted, refreshing sleep.

More information on Gene-Eden and sleep is available on the "About Sleep" web page. Gene-Eden is available on Amazon.com.

Contact:

Tal Davidson
polyDNA
585-563-3200

###

Read the full story at http://www.prweb.com/releases/AntiviralGene-Eden/BetterSleep/prweb3033334.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Major Central Florida Label Printer Creates On-Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers
2. Gateway Responding To Increased Need for Treatment Among Middle-Income Substance Abusers
3. Hospital Corporation of America Recognized by InformationWeek as One of Nations Most Innovative Users of Business Technology
4. Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer
5. Fast Food Choices for iPhone(TM) / iPod(R) Touch Users With Celiac / Coeliac & Food Allergies
6. Collexis BiomedExperts.com Achieves 200,000 Registered Users
7. Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose
8. Accenx Information Exchange Platform Live With BayCares RxHistory - Goal to Reach 8,200 Users
9. Kentucky College Simplifies Password Management by Deploying Self Service Solution to 270,000 Campus Users
10. New: Interventional radiology coding users guide
11. Motio and Vitria Deliver Unified Dashboard and OI Capabilities to IBM Cognos Users
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Users of Gene-Eden, a Natural Antiviral, Report less Sleeping Problems in a Recent Study 
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: